Christine Wood

Discovery and Characterization of AZD6738, a Potent Inhibitor of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Kinase with Application as an Anticancer Agent

Kevin M. Foote, J. Willem M. Nissink, Thomas M. McGuire et al. · Journal of Medicinal Chemistry · 2018 · 331 citations · Full text

Medicine, Oncology, Pharmacology +16

Discovery of 4-{4-[(3<i>R</i>)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1<i>H</i>-indole (AZ20): A Potent and Selective Inhibitor of ATR Protein Kinase with Monotherapy in Vivo Antitumor Activity

Kevin M. Foote, Kevin Blades, Anna Cronin et al. · Journal of Medicinal Chemistry · 2013 · 215 citations · Full text

Medicine, Oncology, Pharmacology +13

Parent Support and Parent-Mediated Behaviors Are Associated with Children's Sugary Beverage Consumption

Nanette V. Lopez, Guadalupe X. Ayala, Kirsten Corder et al. · Journal of the Academy of Nutrition and Dietetics · 2012 · 75 citations · Full text

Medicine, Child Health, Nutrition +15

Abstract 2348: Discovery of AZD6738, a potent and selective inhibitor with the potential to test the clinical efficacy of ATR kinase inhibition in cancer patients.

Clifford D. Jones, Kevin Blades, Kevin M. Foote et al. · Cancer Research · 2013 · 37 citations

Life Sciences, Oncology, Pharmacology +16

Selective non zinc binding inhibitors of MMP13

Chris De Savi, Andrew Morley, Attilla Ting et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 22 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11